Nascent Pharma Holdings, Inc.
NASC
$0.02
$0.00-8.33%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.90K | -- | 26.60K | 34.00K | 31.30K |
| Total Receivables | 1.42M | 3.40M | 3.60M | 3.72M | 6.61M |
| Inventory | 155.90K | 563.40K | 593.40K | 1.62M | 959.70K |
| Prepaid Expenses | 10.10K | 10.10K | 10.10K | 4.10K | 29.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 0.00 | -- |
| Total Current Assets | 1.59M | 3.98M | 4.23M | 5.38M | 7.63M |
|
|
|||||
| Total Current Assets | 1.59M | 3.98M | 4.23M | 5.38M | 7.63M |
| Net Property, Plant & Equipment | -- | 685.70K | 841.20K | 4.40M | 5.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 3.40K | 95.10K | 98.10K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 262.30K | 255.90K | 248.60K | 248.60K | 248.90K |
| Total Assets | 1.86M | 4.92M | 5.32M | 10.13M | 13.08M |
|
|
|||||
| Total Accounts Payable | 2.63M | 2.61M | 2.27M | 1.95M | 4.05M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 457.90K | 448.90K | 366.20K | 357.20K | 348.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.56M | 8.05M | 7.76M | 8.82M | 8.44M |
| Total Finance Division Other Current Liabilities | -- | -- | 1.80K | 1.80K | 22.60K |
| Total Other Current Liabilities | -- | -- | 1.80K | 1.80K | 22.60K |
| Total Current Liabilities | 11.64M | 11.11M | 10.39M | 11.13M | 12.86M |
|
|
|||||
| Total Current Liabilities | 11.64M | 11.11M | 10.39M | 11.13M | 12.86M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 457.90K | 448.90K | 366.20K | 357.20K | 348.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.64M | 11.11M | 10.39M | 11.13M | 12.86M |
|
|
|||||
| Common Stock & APIC | 96.38M | 96.71M | 94.64M | 93.66M | 93.07M |
| Retained Earnings | -113.93M | -110.67M | -107.48M | -102.43M | -100.62M |
| Treasury Stock & Other | -453.10K | -453.10K | -453.10K | -453.10K | -453.10K |
| Total Common Equity | -18.01M | -14.41M | -13.29M | -9.22M | -8.00M |
|
|
|||||
| Preferred Stock Redeemable | 0.00 | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 8.22M | 8.22M | 8.22M | 8.22M | 8.22M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 8.22M | 8.22M | 8.22M | 8.22M | 8.22M |
|
|
|||||
| Total Common Equity | -18.01M | -14.41M | -13.29M | -9.22M | -8.00M |
| Total Preferred Equity | 8.22M | 8.22M | 8.22M | 8.22M | 8.22M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.79M | -6.19M | -5.07M | -1.00M | 219.60K |
|
|
|||||